Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...
It was originally intended to treat non-Hodgkin’s lymphoma but has been repurposed ... Casanovas said: “Dupilumab is paving the way in pricing for other biologics to enter the market.
Speakers at the European Respiratory Society Congress 2024 provided updates to the 2 trials focusing on depemokimab for severe asthma and dupilumab for pediatric asthma. Alexander Mathioudakis ...
Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...
In this review, we compile the latest research on macrophages in conditions such as atopic dermatitis, psoriasis, systemic sclerosis, systemic lupus erythematosus, rosacea, bullous pemphigoid, ...
Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) compared with standard-of-care treatments for patients with ER ...
A few cases of malignancy were reported in separate trials conducted by Silverberg et al. and Blauvelt et al., respectively. There was one case of T-cell lymphoma, one case of pancreatic cancer ...